S

Stern Cardiovascular | Germantown, TN

Research site

(Unclaimed)

Location

8060 Wolf River Boulevard, Germantown, Tennessee, United States of America

Site insights

Top conditions

Top treatments

Ranibizumab

INL1

AB-1002

EYE103

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 11 total trials

A Study of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DME (BAROLO)

EYE-RES-103 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of remigromig (EYE103) in comparison wi...

Active, not recruiting

Diabetic Macular Edema (DME)

Drug: Ranibizumab

Drug: Remigromig

A Study to Evaluate the Efficacy and Safety of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DME (BRUNELLO)

EYE-RES-102 is a randomized, double masked pivotal study to evaluate the efficacy and safety of 2 dose levels of remigromig (EYE103) in comparison wi...

Active, not recruiting

Diabetic Macular Edema (DME)

Drug: Remigromig

Drug: Ranibizumab

Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure (GenePHIT)

This is a Phase 2 adaptive, double-blinded, placebo-controlled, randomized, multi-center trial study to evaluate the safety and efficacy of a single...

Active, not recruiting

Congestive Heart Failure

Drug: AB-1002